Downregulation of miR-544 in tissue, but not in serum, is a novel biomarker of malignant transformation in glioma

By            

Oncology Letters, Vol. 4, Iss. 6, 2012-01 ,pp. : 1321-1324

Spandidos Publications

Access to resources Recommend Favorite

HtrA1: Its future potential as a novel biomarker for cancer

By        

Oncology Reports, Vol. 34, Iss. 2, 2015-01 ,pp. : 555-566

Spandidos Publications

Access to resources Recommend Favorite

Surgical staging of ovarian low malignant potential tumors

By Leiserowitz Gary  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 29-30

Informa Healthcare

Access to resources Recommend Favorite

Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors

By Chandramohan Vidyalakshmi   Mitchell Duane A   Johnson Laura A   Sampson John H   Bigner Darell D  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 977-990

Future Medicine

Access to resources Recommend Favorite

Clinical potential of resistin as a novel prognostic biomarker for cellulitis

By            

Experimental and Therapeutic Medicine, Vol. 9, Iss. 5, 2015-01 ,pp. : 1875-1880

Spandidos Publications

Access to resources Recommend Favorite